APA (7th ed.) Citation

Freedman, S., Sathe, M., Clarkin, M., Gallotto, D., & Borowitz, D. (2025). WS04.06Observations on CFTR modulators and pancreatic function in a clinical trial of ANG003, a novel pancreatic enzyme replacement therapy in people with cystic fibrosis. Journal of cystic fibrosis, 24, S9. https://doi.org/10.1016/j.jcf.2025.03.515

Chicago Style (17th ed.) Citation

Freedman, S.D, M. Sathe, M. Clarkin, D. Gallotto, and D. Borowitz. "WS04.06Observations on CFTR Modulators and Pancreatic Function in a Clinical Trial of ANG003, a Novel Pancreatic Enzyme Replacement Therapy in People with Cystic Fibrosis." Journal of Cystic Fibrosis 24 (2025): S9. https://doi.org/10.1016/j.jcf.2025.03.515.

MLA (9th ed.) Citation

Freedman, S.D, et al. "WS04.06Observations on CFTR Modulators and Pancreatic Function in a Clinical Trial of ANG003, a Novel Pancreatic Enzyme Replacement Therapy in People with Cystic Fibrosis." Journal of Cystic Fibrosis, vol. 24, 2025, p. S9, https://doi.org/10.1016/j.jcf.2025.03.515.